Kobayashi Pharmaceutical Co Ltd (4967)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Kobayashi Pharmaceutical Co Ltd (4967) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011040
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body warmers. It also offers health food products, dietary food products, nutritional supplements, skin care products, medical equipment, devices and ventilators to medical institutes and hospitals, transportation, insurance, production, advertising planning, synthetic resin products and real estate management services. Kobayashi also sells nutrition supplemental foods, and skin care products. The company operates through its subsidiaries and has presence in North America, Europe, Asia. Kobayashi is headquartered in Chuo-ku, Osaka, Japan.

Kobayashi Pharmaceutical Co Ltd (4967) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kobayashi Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Ozone Pharma Enters Into Co-Marketing Agreement With Kobayashi Pharma 10
Acquisition 11
C. R. Bard Acquires 50% Joint Venture Interest in Medicon from Kobayashi Pharma 11
Mitsubishi Completes Acquisition Of Remaining 20% Stake In Japan Medicalnext 12
Mitsubishi Completes Acquisition Of 80% Stake In Japan Medicalnext 13
Kobayashi Pharmaceutical Co Ltd – Key Competitors 14
Kobayashi Pharmaceutical Co Ltd – Key Employees 15
Kobayashi Pharmaceutical Co Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Key Facts, 2016 2
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kobayashi Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kobayashi Pharmaceutical Co Ltd, Deals By Market, 2011 to YTD 2017 8
Kobayashi Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ozone Pharma Enters Into Co-Marketing Agreement With Kobayashi Pharma 10
C. R. Bard Acquires 50% Joint Venture Interest in Medicon from Kobayashi Pharma 11
Mitsubishi Completes Acquisition Of Remaining 20% Stake In Japan Medicalnext 12
Mitsubishi Completes Acquisition Of 80% Stake In Japan Medicalnext 13
Kobayashi Pharmaceutical Co Ltd, Key Competitors 14
Kobayashi Pharmaceutical Co Ltd, Key Employees 15
Kobayashi Pharmaceutical Co Ltd, Subsidiaries 17
Kobayashi Pharmaceutical Co Ltd, Joint Venture 18

★海外企業調査レポート[Kobayashi Pharmaceutical Co Ltd (4967)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boone Electric Cooperative:企業の発電所・SWOT分析2018
    Boone Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • HRG Group, Inc. (HRG):企業の財務・戦略的SWOT分析
    HRG Group, Inc. (HRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aksa Enerji Uretim AS (AKSEN):電力:M&Aディール及び事業提携情報
    Summary Aksa Enerji Uretim A.S. (Aksa Enerji), a subsidiary of Kazanci Holding A.S., is an independent power generation company. The company produces electricity through natural gas, fuel oil, hydro and wind power plants. Apart from power generation and sale, it also provides services such as projec …
  • Curtiss-Wright Corp (CW):企業の財務・戦略的SWOT分析
    Curtiss-Wright Corp (CW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • State Bank Of India
    State Bank Of India - Strategy, SWOT and Corporate Finance Report Summary State Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Austin Industries, Inc.:企業の戦略・SWOT・財務情報
    Austin Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Austin Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SAP SE (SAP):企業の財務・戦略的SWOT分析
    SAP SE (SAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Landeskreditbank Baden-Wuerttemberg-Foerderbank:企業の戦略・SWOT・財務分析
    Landeskreditbank Baden-Wuerttemberg-Foerderbank - Strategy, SWOT and Corporate Finance Report Summary Landeskreditbank Baden-Wuerttemberg-Foerderbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • ReCor Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary ReCor Medical Inc (ReCor Medical), a subsidiary of Otsuka Holdings Co Ltd, is a medical device company that designs and manufactures a proprietary ultrasound ablation system for performing renal denervation. The company develops paradise renal denervation system, a therapeutic non-focused ul …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Yanzhou Coal Mining Co Ltd:戦略・SWOT・企業財務分析
    Yanzhou Coal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanzhou Coal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Luye Pharma Group Ltd (2186):企業の財務・戦略的SWOT分析
    Summary Luye Pharma Group Ltd (Luye Pharma), a subsidiary of Luye Life Sciences Group Ltd is a drug development company that discovers, manufactures, and commercializes novel formulations, generic drugs, and pharmaceutical products. The company offers its products in the form of tablets, formulation …
  • Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eydo Pharma SAS (Eydo Pharma) develops anti-bacterial medicines from essential oils and natural plant molecules for the treatment of infections caused by resistant bacteria. The company developed a pipeline of compounds and formulations such as EP1012, EP1010, EP1011, EP1014, EP1015, EP1020 …
  • ARMO Biosciences Inc:企業のM&A・事業提携・投資動向
    ARMO Biosciences Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ARMO Biosciences Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • RSWM Ltd. (RSWM):企業の財務・戦略的SWOT分析
    RSWM Ltd. (RSWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • HollyFrontier Corporation (HFC)-石油・ガス分野:企業M&A・提携分析
    Summary HollyFrontier Corporation (HollyFrontier) is an independent energy company. It carries out crude oil refining and wholesale marketing of refined petroleum products. The company produces and markets high-value light products such as gasoline, diesel, jet fuel, specialty lubricant products, he …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Asbury Automotive Group, Inc.:企業の戦略・SWOT・財務情報
    Asbury Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Asbury Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The Higashi-Nippon Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Higashi-Nippon Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Higashi-Nippon Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆